A new medicines manufacturing innovation centre that will solve major pharmaceutical industry challenges and accelerate access to affordable medicines has today topped out.

Located in Renfrewshire, at the heart of the emerging Advanced Manufacturing Innovation District Scotland (AMIDS), the £35 million facility is set to develop next-generation pharmaceutical manufacturing processes to drive forward innovation in the medicines supply chain.

The facility has been pioneered through a public-private collaboration between technology innovation organisation, CPI, the University of Strathclyde, UK Research and Innovation, Scottish Enterprise and founding industry partners, AstraZeneca and GSK.

Innovation in novel medicines and the pharmaceutical supply chain is critical for adapting to the changing needs of global populations and driving a healthier society. The environmental and financial implications of pharmaceutical manufacturing can hinder the ability to efficiently respond to global health challenges and streamline medicine supply to patients… Read more